Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionCamden Capital, LLC
Latest Disclosed Ownership7,999 shares
Latest Disclosed Value $ 1,114,887
Camden Capital, LLC reports 0.40% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 11, 2026 - Camden Capital, LLC filed a 13F-HR form disclosing ownership of 7,999 shares of Gilead Sciences, Inc. (CH:GILD) valued at $1,114,887 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 30, 2026 disclosing 8,031 shares of Gilead Sciences, Inc.. This represents a change in shares of -0.40% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F GILEAD SCIENCES INC COM Stock 375558103 7,999 -32 -0.40 1,115 13.10 0.0731
2026-01-30 2025-12-31 13F GILEAD SCIENCES COM 375558103 8,031 -65 -0.80 986 9.69 0.0620
2025-11-13 2025-09-30 13F GILEAD SCIENCES COM 375558103 8,096 43 0.53 899 0.67 0.0617
2025-08-14 2025-06-30 13F GILEAD SCIENCES COM 375558103 8,053 -2,029 -20.12 893 -20.99 0.0840
2025-05-13 2025-03-31 13F GILEAD SCIENCES COM 375558103 10,082 1,687 20.10 1,130 45.68 0.1185
2025-01-29 2024-12-31 13F GILEAD SCIENCES COM 375558103 8,395 2,574 44.22 775 58.81 0.0842
2024-11-12 2024-09-30 13F GILEAD SCIENCES COM 375558103 5,821 83 1.45 488 24.17 0.0527
2024-08-06 2024-06-30 13F GILEAD SCIENCES COM 375558103 5,738 2,440 73.98 394 63.07 0.0314
2024-05-15 2024-03-31 13F GILEAD SCIENCES COM 375558103 3,298 -4,295 -56.57 242 -60.81 0.0212
2024-02-05 2023-12-31 13F GILEAD SCIENCES COM 375558103 7,593 4,431 140.13 615 160.59 0.0622
2023-11-03 2023-09-30 13F GILEAD SCIENCES COM 375558103 3,162 -229 -6.75 237 -9.58 0.0279
2023-08-09 2023-06-30 13F GILEAD SCIENCES COM 375558103 3,391 -81 -2.33 261 -9.37 0.0297
2023-05-11 2023-03-31 13F GILEAD SCIENCES COM 375558103 3,472 -540 -13.46 288 -16.28 0.0425
2023-02-13 2022-12-31 13F GILEAD SCIENCES COM 375558103 4,012 -6,862 -63.10 344 -48.73 0.0546
2022-11-08 2022-09-30 13F GILEAD SCIENCES COM 375558103 10,874 7,497 222.00 671 221.05 0.1558
2022-08-03 2022-06-30 13F GILEAD SCIENCES COM 375558103 3,377 -1,784 -34.57 209 -31.92 0.0545
2022-05-06 2022-03-31 13F GILEAD SCIENCES COM 375558103 5,161 1,308 33.95 307 9.64 0.0662
2022-02-28 2021-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 3,853 -1,773 -31.51 280 -28.75 0.0601
2022-02-14 2021-12-31 13F GILEAD SCIENCES COM 375558103 5,410 -216 393 0.0679
2021-11-03 2021-09-30 13F GILEAD SCIENCES COM 375558103 5,626 1,819 47.78 393 50.00 0.0784
2021-08-16 2021-06-30 13F GILEAD SCIENCES COM 375558103 3,807 -719 -15.89 262 -10.58 0.0605
2021-05-10 2021-03-31 13F GILEAD SCIENCES COM 375558103 4,526 280 6.59 293 18.62 0.0786
2021-02-04 2020-12-31 13F GILEAD SCIENCES COM 375558103 4,246 -248 -5.52 247 -13.03 0.0795
2020-10-30 2020-09-30 13F GILEAD SCIENCES COM 375558103 4,494 -1,884 -29.54 284 -42.16 0.1121
2020-08-11 2020-06-30 13F GILEAD SCIENCES COM 375558103 6,378 -895 -12.31 491 -11.05 0.2286
2020-04-13 2020-03-31 13F GILEAD SCIENCES COM 375558103 7,273 -427 -5.55 552 10.40 0.3061
2020-02-10 2019-12-31 13F GILEAD SCIENCES COM 375558103 7,700 7,700 500 0.2391
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.